Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age.: HP5-144/1-2022E-PDF ; HP5-144/2-2022E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.916203&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document |
|
| Note(s) | Issued also in French under title: Recommandations sur l'utilisation du vaccin Comirnaty (3 mcg) de Pfizer-BioNTech contre la COVID-19 chez les enfants de 6 mois à 4 ans. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220481." "Pub.: 220483." Includes bibliographical references (pages 21-23). |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, October 21, 2022. ©2022 |
| Description | 1 online resource (27 pages) + summary (6 pages) |
| ISBN | 9780660458274 9780660458281 |
| Catalogue number |
|
| Departmental catalogue number | 220481 220483 |
| Subject terms | COVID-19 vaccines -- Canada. Vaccination of children -- Canada. COVID-19 vaccines -- Government policy -- Canada. Vaccination of children -- Government policy -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: